If you’ve ever wondered why a university’s research wing costs so much more to run than its lecture halls, a new statistical breakdown offers a clear answer: laboratories consume energy, water, and materials at rates that have little in common with ordinary office spaces.

A comprehensive data roundup published by BestLabTech pulls together more than fifty sustainability benchmarks from labs around the world, and the pattern that emerges is consistent — small operational choices, repeated across thousands of labs, add up to enormous cumulative impact.

Certification numbers show where the effort is concentrated

Start with adoption. More than 4,500 laboratories across 54 countries currently hold My Green Lab certification, a fee-based, externally verified program that has become the industry standard. Pharmaceutical companies have embraced it aggressively: Biogen certified every one of its labs two years ahead of its own target, Sanofi has enrolled 120 of its 150 global R&D labs, and AstraZeneca became the first organization anywhere to reach the program’s newer 2.0 tier. Universities tell a different story. UW-Madison, for example, enrolled only 21 labs over three years against a stated goal of 50 annually — a gap researchers attribute to program design and internal ownership rather than lack of funding. A free alternative exists for budget-conscious institutions: LEAF, a self-assessed framework run by University College London, currently used by 85 institutions worldwide, though without the external verification pharma companies rely on.

Where the energy actually goes

The underlying reason certification matters so much comes down to raw consumption. Lab buildings use five to ten times more energy than office space of the same size, climbing to 100 times more in facilities with clean rooms, almost entirely because of ventilation — six to ten air changes per hour, compared to about one in a typical office.

Cold storage compounds the problem. A standard ultra-low freezer running at -80°C draws close to 20 kilowatt-hours per day, but a University of Edinburgh study found that simply raising the set point to -70°C cuts that by nearly 30%, with zero investment required. Institutions that go further and replace aging units entirely see even larger gains — UCSF’s freezer replacement project cut over 310,000 kilowatt-hours annually across just 43 units, with an eight-year payback period.

Fume hoods carry a comparable cost. Left unmanaged, a single hood can run over $3,000 a year; sash-management programs bring that down substantially, and Harvard’s initiative to keep hoods closed when not in use recovered close to 70% of the associated ventilation energy, worth roughly a quarter-million dollars annually.

Plastic and water complete the picture

Materials use follows a similar logic. Researchers generate an average of 116 kilograms of plastic waste each year, with serological pipettes, pipette tip boxes, and multiwell plates making up the bulk of it by weight. Reuse cuts this substantially — a single reconditioning cycle halves the footprint, and five cycles bring an 80% reduction, without compromising experimental results, according to the underlying research.

Water tells the same story from a different angle: labs consume roughly five times more water per square meter than office buildings, driven largely by autoclaves and single-pass cooling systems, the latter capable of using nearly a million liters per reaction over a year in some chemistry applications.

A sector-wide trend, not an isolated issue

None of this is confined to individual labs. The global pharmaceutical industry’s carbon footprint grew 77% between 1995 and 2019, well ahead of the 49% growth in worldwide emissions over the same stretch, with close to three-quarters of that footprint sitting in supply chains rather than lab floors themselves.

The throughline across all of these figures is that the fixes already exist and mostly cost nothing to implement. Freezer set points, sash discipline, and consumable reuse require no new equipment or research breakthroughs — only the institutional will to apply them consistently, something pharmaceutical companies have clearly prioritized far more than academic institutions so far.